Endocrine Practice

Papers
(The H4-Index of Endocrine Practice is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Abstract #1161252: Efficacy and Safety of Tandem Control IQ without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes639
Abstract #1169579: Achievement of HbA1c <6.5% with ≥5% Weight Loss and Without Hypoglycemia in Patients with Type 2 Diabetes Treatment with Tirzepatide: a Post Hoc Analysis of the SURPASS-1 to -5 S300
Abstract #1495502: Healthcare Providers' Perceptions of Anti-obesity Medications: Results from the OBSERVE Study208
Abstract #1184116: Predictors of Type 2 Diabetes (T2D) Remission using Digital Twin Technology Based on Artificial Intelligence (AI) and Internet of Things (IoT) Technologies187
Abstract #1184564: A 59-year-old man with type 2 diabetes mellitus with severe neuropsychiatric manifestations due to COVID-19 infection80
Abstract #1160606: Quality Improvement project for effective evaluation and management of Osteoporosis in patients admitted with fragility hip fractures50
Abstract #1592635: Diabetic Emergencies Among Patients With Diabetes Mellitus Who Participated in Hajj, 201949
Abstract #1175512: A Case of McCune Albright Syndrome with Multiple Associated Endocrinopathies43
Abstract #1165370: Unique Case of an Adult Patient with Neurofibromatosis Type 1 with Noonan Syndrome (NFNS) Features and Idiopathic Hypoparathyroidism Complicated by Recurrent Episodes of Hypo- and H40
Abstract #1597635: Optimizing Diabetes Management in LADA: Examining the Effect of Routine Antibody Testing, Correct Diagnosis, and Customized Medication Regimens on HbA1c Control: A Case Series Study40
Abstract #1595981: Changes in Fibroblast Growth Factor-23 and the Klotho Protein Axis in Diabetic Nephropathy39
Abstract #1604642: Positive Impact of Mobile Health Intervention for Patients With T2DM35
Abstract #1002859: Delayed Lenvatinib Associated Thyrotoxicosis: A Case of Destructive Thyroiditis after 20 Weeks on Lenvatinib33
Abstract #1003327: Weekly Levothyroxine Therapy for Severe Hypothyroidism in Pregnancy33
Abstract #1082277: Urinary Albumin Creatinine Ratio Had No Significant Association With Retinopathy in Individuals With Type 1 Diabetes Mellitus32
AACE2021-A-1097: Clinical and Biochemical Outcomes of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors in Type 2 Diabetes Mellitus Patients as a Fourth Oral Anti Diabetic Medicine.31
Abstract #1399545: Calcification of Left Atrial Appendage in Autosomal Recessive Hypophosphatemic Rickets Type 2 (ENPP1 Mutation)30
AACE2021-A-1029: Identifying and Addressing the Determinants That Affect Successful Control of Diabetes Mellitus Type II30
Abstract #1004314: Rare Association of Empty Sella Syndrome with Central Diabetes Insipidus Syndrome: A Case Report27
Abstract #997062: Methimazole Induced Agranulocytosis in a Patient with Amiodarone Induced Thyrotoxicosis27
Abstract #1325308: Alkaline Phosphatase Measurement in Oman: A National Survey and the First Report From MENA Region26
Abstract #1182311: A Rare Case of Hyponatremia due to Cerebral Salt Wasting after Transsphenoidal Pituitary Surgery24
Abstract #1180224: Relapsed hyperprolactinemia with no evidence of pituitary tumor in a woman with a history of pituitary microadenoma24
Abstract #1003513: Cushing Syndrome Found to Late24
Abstract #1609126: Erdheim–Chester Syndrome: A Rare Cause of Diabetes Insipidus and Hypogonadotropic Hypogonadism: Case Report24
Abstract #1325612: A Novel Methylation Disorder Resulting in Profound Growth Failure Associated With a Mutation in FBXO2224
Abstract #1319994: Hyperglycemia of Hospital In-Patients With Diabetes: Prevalence, Complications, Comorbidities, and Mortality Rate at SQUH24
Abstract #1168064: Surgical Management of Giant Prolactinomas24
0.065809965133667